Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest
Display:
?
Cancer Type/Condition:  Cervical cancer
Stage/Subtype:  stage IIB cervical cancer
Country:  U.S.A.
Trial Type:  Treatment
Results 1-14 of 14 for your search:
Start Over
Intensity Modulated Radiation Therapy and Cisplatin in Treating Patients with Stage I-IVA Cervical Cancer
Phase: Phase III, Phase II
Type: Treatment
Age: 18 and over
Trial IDs: 110808, NCI-2012-02858, NCT01554397
Chemotherapy and Pelvic Radiation Therapy with or without Additional Chemotherapy in Treating Patients with High-Risk Early-Stage Cervical Cancer after Radical Hysterectomy
Phase: Phase III
Type: Biomarker/Laboratory analysis, Supportive care, Treatment
Age: 18 and over
Trial IDs: RTOG 0724/GOG-0724, NCI-2011-01973, CDR0000654709, GOG-0724, RTOG-0724, NCT00980954
Cisplatin and Radiation Therapy with or without Lymphadenectomy in Treating Patients with Stage IB-IVA Cervical Cancer
Phase: Phase III
Type: Treatment
Age: 18 and over
Trial IDs: 2010-0952, NCI-2011-02400, NCT01365156
Cisplatin and Radiation Therapy With or Without Carboplatin and Paclitaxel in Patients With Locally Advanced Cervical Cancer
Phase: Phase III
Type: Supportive care, Treatment
Age: 18 and over
Trial IDs: ANZGOG-0902/GOG-0274/RTOG-1174, NCI-2011-02978, ANZGOG-0902, CDR0000706698, GOG-0274, RTOG-1174, ANZGOG-0902-GOG-0274, NCT01414608
Standard Radiation Therapy or Intensity-Modulated Pelvic Radiation Therapy in Treating Patients with Endometrial or Cervical Cancer
Phase: Phase III
Type: Biomarker/Laboratory analysis, Supportive care, Treatment
Age: 18 and over
Trial IDs: RTOG 1203, NCI-2012-02001, CDR0000738944, NCT01672892
A Study of VGX-3100 and INO-9012 DNA Vaccine With Electroporation in Patients With Cervical Cancer
Phase: Phase II, Phase I
Type: Treatment
Age: 18 to 70
Trial IDs: HPV-004, NCI-2015-00497, NCT02172911
Cisplatin and Radiation Therapy in Treating Patients with HIV and Stage IB-IVA Cervical Cancer
Phase: Phase II
Type: Treatment
Age: 18 and over
Trial IDs: AMC-081, NCI-2013-01314, NCT01590017
Cisplatin and Radiation Therapy with or without Triapine in Treating Patients with Previously Untreated Stage IB-IVA Cervical Cancer or Stage II-IVA Vaginal Cancer
Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: CASE 4812, NCI-2013-00804, NCI 9434, 9434, NCT01835171
Intensity-Modulated Radiation Therapy, Cisplatin, and Gemcitabine Hydrochloride in Treating Patients With Stage IB-IVA Cervical Cancer
Phase: Phase I
Type: Treatment
Age: 18 and over
Trial IDs: 100597, NCI-2012-02860, NCT01554410
Chemoradiation Therapy and Ipilimumab in Treating Patients with Locally Advanced Cervical Cancer
Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: GOG-9929, NCI-2012-01733, GOG-PIS1102, NCT01711515
Magnetic Resonance Imaging-Based Radiation Therapy and Cisplatin in Patients With Stage I, Stage II, Stage III, or Stage IV Cervical Cancer
Phase: No phase specified
Type: Treatment
Age: 18 and over
Trial IDs: UPCC 01809, NCI-2009-01356, NCT01016561
Proton Beam Radiation Therapy in Treating Patients with Uterine and Cervical Cancer with Regional Lymph Node Metastases
Phase: No phase specified
Type: Treatment
Age: 18 and over
Trial IDs: 10-269, NCI-2011-00894, NCT01600040
Start Over